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Abstract
Cryptococcus neoformans is an encapsulated pathogenic yeast that can change the size of
the cells during infection. In particular, this process can occur by enlarging the size of the
capsule without modifying the size of the cell body, or by increasing the diameter of the cell
body, which is normally accompanied by an increase of the capsule too. This last process
leads to the formation of cells of an abnormal enlarged size denominated titan cells. Previ-
ous works characterized titan cell formation during pulmonary infection but research on this
topic has been hampered due to the difficulty to obtain them in vitro. In this work, we
describe in vitro conditions (low nutrient, serum supplemented medium at neutral pH) that
promote the transition from regular to titan-like cells. Moreover, addition of azide and static
incubation of the cultures in a CO2 enriched atmosphere favored cellular enlargement. This
transition occurred at low cell densities, suggesting that the process was regulated by quo-
rum sensing molecules and it was independent of the cryptococcal serotype/species. Tran-
sition to titan-like cell was impaired by pharmacological inhibition of PKC signaling pathway.
Analysis of the gene expression profile during the transition to titan-like cells showed overex-
pression of enzymes involved in carbohydrate metabolism, as well as proteins from the
coatomer complex, and related to iron metabolism. Indeed, we observed that iron limitation
also induced the formation of titan cells. Our gene expression analysis also revealed other
elements involved in titan cell formation, such as calnexin, whose absence resulted in
appearance of abnormal large cells even in regular rich media. In summary, our work pro-
vides a new alternative method to investigate titan cell formation devoid the bioethical prob-
lems that involve animal experimentation.
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Author summary
Cryptococcus neoformans is a fungal pathogen that has a significant incidence in HIV+
patients in particular, in Sub-saharan Africa, Asia and South America. This yeast poses an
excellent model to investigate fungal virulence because it develops many strategies to
adapt to the host and evade the immune response. One of the adaptation mechanisms
involves the formation of Titan Cells, which are yeast of an abnormal large size. However,
research on these cells has been limited to in vivo studies (mainly in mice) because they
were not reproducibly found in vitro. In this work, we describe several conditions that
induce the appearance of cells that mimic titan cells, and that we denominated as titan-
like cells. The main factor that induced titan-like cells was the addition of serum to nutri-
ent limited media. This has allowed to easily performing new approaches to characterize
several signaling pathways involved in their development. We found that the formation of
these cells is regulated by quorum sensing molecules, and that pathways such as cAMP
and PKC regulate the process of cellular enlargement. We have also performed transcrip-
tomic analysis, which led to the identification of new genes that could be involved in the
process. This work will open different research lines that will contribute to the elucidation
of the role of these cells during infection and on the development of cryptococcal disease.
Introduction
Cryptococcus neoformans is a basidiomycetes yeast widely distributed in the environment that
can behave as a pathogen in susceptible patients [1, 2]. Cryptococcus neoformans can survive in
the lung, but in immunosuppressed patients it can also spread to the central nervous system
and cause meningoencephalitis [2]. Cryptococcal infections are major causes of death in HIV
patients. Although the incidence has significantly decreased in developed countries due to the
introduction of antiretroviral therapy (ART), associated mortality remains high [3, 4]. More-
over, infections by this yeast still present a high incidence in developing areas, such as the sub-
Saharan Africa and Southeast Asia [5, 6].
One of the most characteristic features of Cryptococcus is its ability to adapt to the lung envi-
ronment and to evade the host immune response. Several factors contributing to cryptococcal
adaptation to the lung have been described. The most important is the presence of a polysac-
charide capsule [7–9], which is antiphagocytic and protects the yeasts from stress conditions
[2, 10]. The size of the capsule is not constant, and it increases during the first hours of interac-
tion with the host [11], which indicates that this process is a response that contributes to
immune evasion. Furthermore, the capsular polysaccharide is also secreted to the extracellular
media where it induces immunological paralysis through multiple mechanisms [9, 12–15].
Cryptococcus neoformans is also a facultative intracellular pathogen in phagocytic cells [16–19],
which is another important factor that contributes to fungal survival in the host.
Cryptococcus has also developed other adaptation mechanisms that contribute to the eva-
sion of the immune response. One of them involves the formation of titan cells, which have an
abnormal large size. The average diameter of Cryptococcus cells grown in vitro ranges between
4–7 microns. In contrast, the fungal population in the lungs is very heterogeneous, and cells of
even 100 microns have been described [11, 20–22]. Titan cells have been arbitrarily defined as
those with a cell body diameter above 15 microns or with a total size (capsule included) over
30 microns [23]. Because of their size, titan cells cannot be phagocytosed, and they can persist
in the host for long periods [24, 25]. Titan cells also contribute to virulence through other
mechanisms. For example, they can divide and produce a progeny of regular size that has
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increased resistance to stress factors [26] as well as the ability to inhibit the phagocytosis of
cells of regular size [25].
Some signals and pathways involved in titan cell formation have been characterized, and it
is known that the cAMP pathway is required for this phenomenon [20, 21, 27]. Titan cell for-
mation has been associated in vivowith anti-inflammatory Th2 type immune responses [23],
but the host’s factors that trigger this morphological transition remain unknown.
The investigation and characterization of titan cells has been limited by the lack of media
allowing the transition in vitro, so most of the data about these cells has been obtained using
animal models. Although this approach has been shown to be useful for some purposes, it does
not allow obtaining a large population of titan cells. In addition, the use of mice for these pur-
poses presents associated significant bioethical issues. In this work, we have defined in vitro
conditions that induce cell enlargement in C. neoformans, which lead to the appearance of cells
similar to those found in vivo, here denominated titan-like cells. We found that incubation of
this fungus in low nutrient media supplemented with serum in a CO2 enriched atmosphere
induced cryptococcal cell size increase. Moreover, other factors, such as oxygen limitation, or
low cell density enhanced the cell growth. We have used this medium as a first step in the char-
acterization of this transition. Our findings open future research lines that will help to define
the molecular mechanisms that trigger titan cell formation and their role during infection.
Results
Cryptococcus neoformans can significantly enlarge its cell size in vitro
In the last years, we have characterized the phenomenon of capsule growth in vitro using a
medium that contains 10% Sabouraud buffered at pH 7.3 with 50 mM MOPS. In a set of experi-
ments, we observed that addition of serum and of the respiration inhibitor sodium azide to this
medium produced not only growth of the capsule but also of the cell body (Fig 1A–1C). These
cells resembled the titan cells observed in vivo, although they did not reach the same size.
Despite this difference, we argued that this phenomenon might reflect the first steps of titan cell
formation, so we decided to characterize the factors that induced in vitro cell growth. First, the
morphology of C. neoformans was analyzed in regular growth conditions (liquid Sabouraud), in
capsule inducing medium (10% Sabouraud buffered with 50 mM MOPS) and in 5% Sabouraud
buffered with MOPS and 5% FBS + azide (15 μM). Titan cells have been defined as those with
total diameter of 30 μm or those with a cell body diameter larger than 15 μm [22]. As shown in
Fig 1D, we observed a significant increase of both the cell size and the capsule in this last
medium, almost reaching the threshold for titan cells definition after three days of culture. For
this reason, we decided to name the medium as TCM (Titan Cell Medium).
Characterization of factors that induce cellular growth in vitro
Serum was essential for cellular enlargement formation because in its absence the increase in
cell size was significantly lower (p<0.05, Fig 2A). We characterized in detail the factors and
conditions that favor cryptococcal cell size increase in vitro. In our initial experiments, the
medium in which we first observed cells of enlarged size contained subinhibitory concentra-
tions of the mitochondrial inhibitor sodium azide to prevent contamination. As shown in Fig
2B, the process of cell enlargement was enhanced in the presence of sodium azide. This com-
pound is an inhibitor of complex IV of the respiratory chain, so we argued that other factors
that alter respiration could induce increases in cell size. For this reason, we investigated
whether cryptococcal cell growth was influenced by oxygen limitation. To assess that, we com-
pared the yeast morphology under shaking or static conditions. As shown in Fig 2C, static
incubation of the cultures resulted in a greater proportion of cells with enlarged size.
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Cryptococcal cells sense and respond to environmental levels of CO2 and it is known that
this molecule induces capsule growth. For this reason, we investigated if incubation of the cul-
tures in a CO2-enriched environment altered cryptococcal cell size. We found that yeast size
was significantly larger when the plates were placed in a 5% CO2 atmosphere in comparison to
growth without CO2 (Fig 2D).
To visualize the phenomenon of cell growth, we carried out in vivo imaging by placing the
cells in a 96-wells plate in TCM in 5% CO2 at 37˚C under a microscope overnight and obtained
videos of the cellular enlargement. As shown in S1 Video, cells actively grew and replicated in
Sabouraud medium. However, in TCM, after 5–8 h of incubation the cells started to enlarge
during 8–10 h (S2 Video). After this time, the cells stopped enlarging and continued budding.
We also observed that cellular enlargement was associated with some intracellular phenotypic
changes. For instance, a significant proportion of the cells displayed an intracellular compart-
ment that started to divide by fission, but then fused again to render a large vesicle (S3 Video).
To evaluate to which extent the cells obtained in vitro resembled titan cells found in animal
models, we infected mice and isolated cryptococcal cells after 14 days of infection (see Material
& Methods). We first determined the total size, capsule size, and cell body size of titan cells. As
shown in Fig 3, the cells obtained in vitro in TCM did not reach the size found in the cells in
vivo. The main difference between both types of cells was at the capsule, being it size signifi-
cantly larger in titan cells isolated from mice. For this reason, we decided to denominate the
cells obtained in vitro as “titan-like” cells.
Fig 1. Cellular and capsular size of C. neoformans in different media. Cells from strain H99 were inoculated into
Sabouraud (A), capsule inducing medium (10% Sabouraud with MOPS at pH 7.3) (B) and 5% Sabouraud with MOPS
+ 5% FBS + sodium azide (C). After incubation at 37˚C with shaking, total size and capsule size was visualized by
suspending the cells in India ink. Total size (D), cell body size (E) and capsule size (F) distribution after incubation as
described above. The asterisks indicate significant differences compared to Sabouraud control (p<0.05). Sab, Sabouraud
medium.
https://doi.org/10.1371/journal.ppat.1007007.g001
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Titan cells also present differences in capsular features, such as the density, compared to
cells obtained in vitro [21]. To investigate if the density of titan-like cells was similar to that
observed in vivo, we measured the permeability index using fluorescently labeled dextrans of
different molecular weights (70 and 40 kDa). As shown in Fig 3D and 3E, penetration of the
dextrans in the capsule of titan-like cells was reduced compared to cells of regular size and sim-
ilar to that of titan cells isolated from the lung of infected mice. This result indicated that titan-
like cells had a capsule of similar density of that of titan cells generated in vivo.
Although serum was required to induce cellular enlargement in vitro, it was not sufficient
for this process. Serum did not induce cellular growth in rich media (Fig 4A and 4B), in
Fig 2. Effect of different factors on the cellular growth of C. neoformans. Cells from H99 strain were incubated on Sabouraud overnight and transferred to
different media to evaluate the effect of several factors on the titan-like cell formation. (A) Cells were incubated in Sabouraud or capsule inducing medium
(10% Sab, pH 7.3) supplemented with 15 μM sodium azide in the presence or absence of 5% serum (FBS) and cultures were incubated at 37˚C overnight.
Pictures after suspension of the cells in India Ink were taken, and the total cell size was measured and plotted (B) Effect of sodium azide (black bars) on cell
size in Sabouraud or TCM medium. As a control, the same media were inoculated without sodium azide (white bars). Cells were incubated at 37˚C
overnight. Pictures after suspension of the cells in India Ink were taken, and the total cell size was measured and plotted (C) Effect of shaking effect on titan-
like cell formation. The yeasts were incubated at 37˚C for 24 h in flasks with Sabouraud or TCM medium in both conditions (black bars, shaking) and (gray
bars, no shaking). Pictures after suspension of the cells in India Ink were taken, and the total cell size was measured and plotted (D) Effect of CO2 on cell
growth. The cells were incubated in Sabouraud (white bars) and TCM (black bars) with and without 5% of CO2. In both cases, the cells were grown at 37˚C
without shaking for 24 h in a 96-microdilution plate. Then, the plate was directly observed in the microscope, and the cell body size of was measured and
plotted.
https://doi.org/10.1371/journal.ppat.1007007.g002
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contrast to the situation in the diluted medium nutrients (Fig 4C), indicating that nutrient lim-
itation was important for cell size enlargement.
Effects of phospholipids from fetal calf serum in titan-like cell formation
Phospholipids, in particular phosphatidylcholine, can trigger the appearance of titan cells in
vitro [28]. For this reason, we performed a lipid extraction of fetal calf serum, present in TCM
and we incubated the cells with different amounts of these lipids (1/40, 1/100 and 1/200 dilu-
tion of the original lipid solution). As shown in Fig 4D, the lipids present in the serum induced
titan-like cell formation.
Phosphatidylcholine (PC) is one of the major phospholipids contained in serum and mamma-
lian membranes. For this reason, we investigated if this molecule had any effect on titan-like cell
formation. We performed experiments in which serum was replaced by different concentrations
of PC, and compared its effect with control samples containing the same concentration of solvent
(ethanol). As shown in Fig 4E, PC induced an increase in cryptococcal cell size. However, this
increase was lower compared to the one observed with serum, indicating that although PC seemed
to induce titan-like cells, there are other serum components responsible for the cell increase.
Cell density influences titan-like cell formation
We found that titan-like cell formation depended on the cell density of the cultures. We inocu-
lated 96-wells plates with different concentrations of cells from H99 strain (106, 105, 104 and
103 cells/mL) in TCM and Sabouraud as a control of growth. After overnight incubation at
37˚C with CO2, titan-like cells were observed in the wells inoculated with 10
3, 104 and 105
Fig 3. Comparison of titan cells obtained in vivo with enlarged cells obtained in vitro. Measurements of cell body (A), capsule (B) and total cell sizes (C) of
cells isolated from infected mice (in vivo) and cultured in TCM and Saboraud in vitro. D and E show the permeability index of 70 and 40 kDa fluorescent
labelled dextrans respectively in the same type of samples (see M&M).
https://doi.org/10.1371/journal.ppat.1007007.g003
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cells/mL but were almost absent in the wells that were inoculated with the higher cell density
(106 cells/mL, Fig 5A). We found that titan-like cells were observed more frequently when the
cultures were inoculated with cellular concentrations around 104 cells/mL.
Effect of QS molecules on titan-like cell formation
The fact that the formation of titan-like cells depends on cell density suggests that this process
could be regulated by quorum sensing (QS). QS is a cell-cell communication mechanism
mediated by molecules that are released directly into the medium by microorganisms. These
molecules are released as a function of growth and replication rate [29, 30]. In this way, we
evaluated the influence on titan-like cell formation of cell-free media obtained from titan-like
and regular C. neoformans cultures. We inoculated TCM with the H99 strain at 106 cells/mL
and 104 cells/mL and incubated the cultures for 18 h at 37˚C in 5% CO2 to obtain cells of regu-
lar size and titan-like cells, respectively. We then collected the supernatants (named RCS and
TCS, respectively). These conditioned media were added to wells that contained fresh TCM
inoculated at 104 cells/mL. We found that the conditioned medium RCS significantly inhibited
the formation of titan-like cells (Fig 5B) even when added to fresh TCM (TCM + RCS)
(p<0.001). In contrast, the supernatant from titan-like cells cultures (TCS) did not block the
formation of the titan-like cells, demonstrating a negative effect of the supernatant obtained
from cells of regular sizes on titan-like cell formation (Fig 5B). The effect of the TCS condi-
tioned medium was not explained by the dilution of the nutrients of the fresh TCM, since
titan-like cells were still formed in TCM diluted with distilled water (Fig 5B).
In C. neoformans, the main QS molecule described is a short peptide (11-mer) called Qsp1
that is required for fungal virulence, replication, cell wall synthesis and protease activities [31,
32]. To investigate the influence of Qsp1 in the formation of titan-like cells, different concen-
trations of the peptide were added to the TCM medium and the formation of titan-like cells
was evaluated. We observed that Qsp1 significantly inhibited formation of titan-like cells in a
dose-dependent manner (Fig 5C). As control, we used both inactive and scrambled versions of
Qsp1, and observed that none of them had any effect on titan-like cell development (Fig 5C).
It could be argued that the production of Qsp1 in TCM cultures inoculated at high cell den-
sities was responsible for the inhibition of titan-like cell formation. To test this idea, we used a
qsp1mutant that does not produce Qsp1 [32]. Our results showed that the mutant produced
titan-like cells in a similar way as the wild type strain KN99 (Fig 5D) [32], even at high cell den-
sities (106 cells/mL). This result indicates that absence of titan-like cells in TCM cultures inoc-
ulated at high densities was not only due to Qsp1, and that most probably, other QS molecules
secreted by C. neoformans might influence cellular enlargement.
Nuclear staining
Titan cells formed in the lungs are polyploid and single-nucleated. So we investigated the mor-
phology of the nucleus and the DNA content after staining with DAPI. As shown in Fig 6A
Fig 4. Effect of serum on cryptococcal cell growth. H99 cell suspensions were inoculated in Sabouraud (A),
Sabouraud supplemented with 5% serum (B) or TCM (C). The cells were incubated overnight at 37˚C in 5% CO2.
Then, the cells were suspended in India Ink and pictures of the cell body size were taken. The scale in A applies to all
the pictures. (D) Effect of purified serum lipids on cell growth. The cells (initial density 104 cells/mL) were grown in
TCM medium in which the serum was replaced by different dilutions (40, 100 and 200) of the lipid extract. As
controls, the same media was supplemented with PBS. Cultures in TCM are also included for reference. Cell body size
was determined after 24 hours at 37˚ C with CO2 and shaking. The asterisks indicate significant differences compared
to Sabouraud control. (E) Effect of phosphatydilcholine on titan-like cell formation. Cells were incubated as in (A), but
serum was replaced by 0.1 mM of phosphatidylcholine (PC). A parallel control with the same concentration of ethanol
was carried out in parallel. The graph shows the cell body size.
https://doi.org/10.1371/journal.ppat.1007007.g004
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and 6B, titan-like cells contained one nucleus. This result was confirmed using a strain that
expresses a fluorescent nucleolar protein (NOP1-mCherry, [33], S1 Fig). We also quantified
the fluorescence intensity of the DAPI staining by flow cytometry. As shown in Fig 6C–6E,
titan-like cells emitted more fluorescence than cells of regular size. The fluorescence intensity
Fig 5. Influence of cell density on titan-like cell formation in C. neoformans. (A). Cells from H99 strain inoculated in Sabouraud (white bars) or TCM
(black bars) at different concentrations (103, 104, 105 and 106 cells/mL) in 96-well plates. Cell body size was measured after incubation overnight at 37˚C
with CO2. The asterisks indicate significant differences. B) Effect of conditioned media on cell body size. Cells from H99 strain were incubated in different
conditioned TCM medium denominated (see material and methods) as TCS (supernatant of titan-like cells TCM cultures), RCS (supernatant of regular size
TCM cultures), TCM + TCS (a 1:1 mixture of fresh TCM with TCS), TCM + RCS (a 1:1 mixture of fresh TCM with RCS). As controls we used a diluted
TCM in H2O (1:1) and fresh TCM inoculated with 10
4 cells/mL (TCM) and with 106 cells/mL. (C) Cells from H99 strain were grown in TCM supplemented
with 30 uM and 15 uM of the quorum sensing peptide Qsp1 (NFGAPGGAYPW). As controls, TCM supplemented with 30 uM of an inactive Qsp1
(NFGAPGAAYPW), with 30 uM of a scrambled Qsp1 peptide (AWAGYFPGPNG). TCM without any supplementation was used as control. Cell body size
was measured after overnight incubation at 37˚C with 5% CO2. D) Titan-like cell formation of qsp1mutant. Cells from the KN99 (wild type) and qsp1
mutant were inoculated in TCM at 104 and 106 cells/mL, and cell body size was determined after 18 h of incubation at 37˚C in the presence of 5% CO2.
https://doi.org/10.1371/journal.ppat.1007007.g005
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was more heterogeneous in titan-like cells, ranging from 2 to 5-fold increase compared to cells
of normal size (Fig 6E).
Inhibition of PKC signaling pathways affected titan-like cell formation
PKC is a family of protein kinases, activated by Ca2+, diacylglycerol (DAG) and phospholipids,
and involved in different virulence-related aspects in C. neoformans such as melanin produc-
tion [34], temperature tolerance, cell integrity [35] and fluconazole tolerance [36]. We argued
that serum phospholipids could activate the PKC signaling pathway, so we tested the effect of
three PKC inhibitors, calphostin C, staurosporine and bisindolylmaleimide I on titan-like cell
formation. We observed that all PKC inhibitors (in particular, staurosporine and Calphostine
C), impaired the formation of titan-like cells in a dose-dependent manner (Fig 7A–7C). We
also included the tyrosine kinase inhibitor genistein and found that this compound had no vis-
ible effect on cellular enlargement (Fig 7D).
Titan-like cell formation did not correlate with the serotype or mating type
of the strain
Cryptococcus neoformans is divided in different serotypes and varieties: variety grubii (serotype
A), variety neoformans (serotype D), and A/D hybrids. It has been proposed that these groups
should be divided into different species [37], although recent reports argue against this differ-
entiation and suggest the term of species complexes [38]. We investigated if there was a corre-
lation between the main species complex of the strain and the formation of titan-like cells. As
Fig 6. Nuclear staining of titan-like cells. Cells of regular size and titan-like cells were obtained by inoculating H99 strain in TCM at 106 and 104 cells/mL
respectively. After incubating overnight at 37˚C with 5% CO2, the cells were fixed and stained with DAPI as described in material and methods. A and B show
the microscopic appearance of the nucleus of cells of regular size (A), and titan-like cells (B). C-E, Analysis of nuclear staining by flow cytometry. C) FFS/SSC
scatter plot of cells of regular size, D) same graph of titan-like cells. In C and E, we defined a gate to clearly separate cells of regular size (cells in blue) and
titan-like cells (cells in light red). The fluorescence intensity (histograms) of the cells from these two gates is represented in panel E. Blue histogram,
fluorescence from the cells shown in the gate in panel C, and light red histogram, fluorescence from the cells shown in the gate in panel D.
https://doi.org/10.1371/journal.ppat.1007007.g006
In vitro characterization of titan-like cells in Cryptococcus neoformans
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007007 May 18, 2018 10 / 37
shown in Fig 8A–8C, for each serotype/species complex, there were strains with high and low
capacity to induce titan-like cells, which indicates that there was not a direct association
between the serotype and cell growth.
We also investigated the behavior of strains from the related species C. gattii, which can
infect immunocompetent patients. As shown in Fig 8D, there were strains that had high and
low ability to induce titan-like cells. We next examined if the hyper (CBS10514, R265) and
Fig 7. Influence of PKC pathway on titan-like cell formation. The influence of the PKC pathway was evaluated by its inhibition with three different
agents: Bisindolylmaleimide I (A), Calphostin C (B), Staurosporine (C). Genestein, a tyrosine kinase inhibitor, was used as control (D). The
experiments in A, B and D were performed the same days, so they share the same control. However, for clarity, the graphs corresponding to each
inhibitor have been separated. The experiments were repeated on three days, and the data from the three experiments is plotted. Cells of the H99 strain
were incubated with these different agents overnight in TCM at 37˚C with 5% CO2 without shaking and cell body size was measured. The asterisks
indicate statistical significant differences.
https://doi.org/10.1371/journal.ppat.1007007.g007
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hypovirulent (CBS10865, R272) strains isolated at the Vancouver outbreak [39, 40] formed
titan-like cells in a different way. Interestingly, the hypervirulent strain tended to produce
more titan-like cells compared to the strain with reduced virulence (Fig 8D). We also tested
other C. gattii strains (NIH 191 and NIH198), which also presented differences in their capac-
ity in producing titan-like cells. In summary, the many inter-strain differences in the capability
to form titan-like cells did not allow associating this ability to the serotype/genotype of the
isolates.
Coinfection with a and α strains results in a higher proportion of titan cells in the lungs
[20], so we investigated whether strains from different mating type had different ability to
form titan-like cells. We studied three pair of strains with different mating type JEC20/JEC21,
NE822/NE824 and 3259/3260 (KN99), and we found that the pair 3259/3260 increased the
size of the cell body in the TCM medium compared to the Sabouraud significantly (p<0.05,
Fig 8E). In NE822/NE824 and JEC20/JEC21 pairs, there was a small increase in cell size in
TCM and we observed a small amount of titan-like cells in this medium although this differ-
ence was not statistically significant. These results indicate that titan-like cell formation can
occur in vitro independently of the mating type of the strains. However, co-incubation of both
mating types did not result in a higher proportion of titan cells in TCM (S2 Fig).
Titan-like cell formation in different mutants
To identify genes that play an important role in the formation of titan-like cells, we studied the
phenotype of mutants with problems to induce capsule growth, such as gat201 or ada2 [41, 42]
or acapsular strains (cap59 and cap60). As shown in Fig 9A, none of these mutants induced cel-
lular enlargement in TCM.
Titan cell formation is regulated by the cAMP pathway [21, 27]. Moreover, the CO2 acti-
vates adenylate cyclase [43, 44]. For this reason, we investigated the formation of these cells in
cac1mutant (which lack the enzyme adenylate cyclase) and in the reconstituted strain cac1/
CAC1. As shown in Fig 9B, the cac1mutant was defective to produce cellular enlargement,
whereas the reconstituted strain produced titan-like cells as the wild type.
CO2 is transformed into HCO3
- by the action of carbonic anhydrases (Can). In C. neofor-
mans, there are two genes encoding these enzymes (CAN1 and CAN2) [44, 45], being Can2 the
most abundant and physiologically active. Since can2mutant can only grow in a CO2 enriched
environment, these strains were maintained always in 5% CO2. Deletion of CAN2 did not have
any effect of titan-like cell formation. Strikingly, in the absence of CAN1, titan-like cell size was
even larger than that observed for the WT strain in TCM (Fig 9C).
Interaction of titan-like cells with macrophages
Titan cells are not phagocytosed in vivo [21, 25]. For this reason, we examined the interaction
between macrophage-like cell lines and titan-like cells obtained in vitro. We compared the
phagocytosis of titan-like cells (incubated in TCM inoculated at 3x104 cells/mL), and of cells of
regular size obtained in TCM inoculated at 106 cells/mL or in Sabouraud. Phagocytosis was
quantified both by microscopic observation and by flow cytometry using a cryptococcal strain
that expressed GFP (see Material and Methods). In all cases, we found that titan-like cells
obtained in vitro were not phagocytosed (Fig 10A and S4 Video). Interestingly, cells of regular
size were not equally internalized, since cells cultivated in Sabouraud medium inoculated at
high cellular density were more efficiently phagocytosed than the same cells inoculum grown
in TCM (S5 and S6 Videos, Fig 10A). This difference was not due to difference in binding to
the antibody used as opsonin in this experiment (18B7, S3 Fig), but correlated with the
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Fig 8. Titan-like cell induction in different strains. Four strains of each species (serotypes) were inoculated into Sabouraud (black
symbols) or TCM (grey symbols) at a density of 104 cells/mL and grown overnight at 37˚C with CO2. (A) C. neoformans var. grubii
(serotype A); (B) C. neoformans var neoformans (serotype D); (C) C. neoformans A/D; (D) C. gattii. (E) MATa and MATα strains: NE822/
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increase in cell size (in particular, due to capsule enlargement) found in cells inoculated in
TCM at high density compared to the cells cultivated in Sabouraud (S3 Fig).
It has been shown that titan cells can also prevent phagocytosis in vivo of cryptococcal cells
of regular size [25], so we tested if titan-like cells induced a similar phenomenon in vitro. For
this purpose, RAW264.7 macrophages were preincubated with titan-like cells for 1 h with
mAb 18B7. As control, parallel samples were incubated only with titan-like cells without mAb
or with medium without yeast cells (with or without mAb). After this time, the plate was
washed to remove titan-like cells, and H99-GFP cells of normal size cultivated in liquid
Sabouraud were added to the macrophages. As shown in Fig 10B, preincubation of the macro-
phages with titan-like cells did not affect the phagocytosis of regular size yeasts (Fig 10B).
Analysis of gene expression profile in titan-like cells
To gain insights about the molecular mechanisms involved in titan-like cell formation, we
compared their gene expression profile with that of cells of regular size.
To this end, cryptococcal cells were inoculated in TCM at low (104 cells/mL, titan-like cells)
and high densities (106 cells/mL, regular cells) at 37˚C with CO2, and total RNA was isolated
after 7 and 18 h of incubation. Differences in gene expression were investigated by RNAseq
(see material and methods). After mapping the reads and subsequent analysis of differentially
expressed genes using the DESeq2 algorithm, we found 42 genes induced at least 1.6-fold in
titan-like cells after 7 h and 400 genes induced at least 2-fold after 18 h (Fig 11). A lower
expression threshold was set for the 7h data to carry out a comparative GO analysis. Interest-
ingly, the number of repressed genes (after 7h) was relatively high (327) and did not increase
after 18 h (312).
Gene Ontology analysis of genes induced at 7 h revealed a moderate increase in genes
involved in the tricarboxylic acid (TCA)/glyoxylate cycle and in response to stress and protein
folding. The effect of the transition was more evident after 18 h (Fig 11B and Table 1), with the
induction of numerous genes involved in carbohydrate metabolism. This included diverse
NE824 (serotype D), 3259/3260 (serotype A) and JEC20/JEC21 (serotype D). Cell body size was measured in all cases. The red lines
represent the mean and standard error.
https://doi.org/10.1371/journal.ppat.1007007.g008
Fig 9. Titan-like cell formation in different mutants. (A) Cells from the capsule deficient mutants gat201, cap59, cap60 and ada2 (H99 background) were
inoculated in Sabouraud and TCM medium at a density of 104 cells/mL in 96-well plates. Cell body size was determined after overnight incubation at 37˚C
with CO2. (B) Role of adenylate cyclase on cell growth of C. neoformans. Cells from the wild-type strain H99, the adenylate cyclase mutant (cac1) and the
reconstituted strain (cac1/CAC1) were incubated as described above. (C) Role of carbonic anhydrases on cell growth. Cells from the wild type strain H99
and KN99 (3260) and the can1 and can2mutants were used for this purpose. Cell body size was determined after overnight incubation at 37˚C with CO2 in
all cases. The asterisks indicate significant differences (see M&M). The red lines represent the mean and standard error.
https://doi.org/10.1371/journal.ppat.1007007.g009
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genes related to glycolysis, such as CNAG_03769 and CNAG_05480, encoding two isoforms
of hexokinase, CNAG_03916 (glucose-6-phosphate isomerase), CNAG_04676 (6-phospho-
fructokinase), CNAG_06770 (fructose-bisphosphate aldolase 1), CNAG_02035 (triose-phos-
phate isomerase) and two isoforms of enolase (CNAG_03072 and CNAG_06868). The TCA
cycle was also affected, with induction of mitochondrial citrate synthase (CNAG_00061), E1
and E2 components of ketoglutarate deshydrogenase (CNAG_03674 and CNAG_03596), the
two subunits of isocitrate dehydrogenase (CNAG_07363 and CNAG_07851), and
CNAG_05653, encoding malate synthase. In addition, genes belonging to the oxidative seg-
ment of the pentose-phosphate shunt were also induced, such as glucose-6-phosphate dehy-
drogenase (CNAG_03245), 6-phosphogluconolactonase (CNAG_02133), and two isoforms of
6-phosphogluconate dehydrogenase (CNAG_04099 and CNAG_07561). Finally, genes
involved in trehalose metabolism, such as CNAG_03113, CNAG_03765, and CNAG_05292,
encoding a trehalose phosphatase and two trehalose synthases, respectively, were upregulated.
Diverse genes encoding closely related enzymes involved in amino sugar metabolism were
also induced, including glutamine-fructose-6-phosphate transaminase (CNAG_01164), phos-
phoacetylglucosamine mutase (CNAG_02445), glucosamine-6-phosphate deaminase
(CNAG_06098), and N-acetylglucosamine-6-phosphate deacetylase (CNAG_06098), plus
CNAG_02355, coding for a UDP-xylose/UDP-N-acetylglucosamine transporter. The expres-
sion of two additional genes related to chitin degradation (CNAG_01239, encoding chitin dea-
cetylase, and CNAG_06659, hexosaminidase), was also increased.
Gene Ontology analysis did not report any significantly enriched category for the set of
gene repressed at 7h when the Benjamini-Hochberg adjustment method was used. However,
when a non-adjusted search was conducted, we found several genes related to ribosome bio-
genesis, DNA repair and DNA replication. In particular, three genes (CNAG_00681,
CNAG_01959, and CNAG_03148) involved in the nuclear condensin complex, required for
Fig 10. Interaction of titan-like cells with murine-like macrophages. A) Cells from H99-GFP strain were incubated in TCM
inoculated at 3x104 cells/mL (titan-like cells), 106 cells/mL (regular cells in TCM), and Sabouraud. Then, phagocytosis
experiments with RAW264.7 cells were performed and quantified by flow cytometry as described in material and methods.
Statistical differences are highlighted. B) Effect of preincubation of macrophages with titan-like cells on the phagocytosis of
regular cells. Titan-like cells were obtained by incubation of C. neoformans in TCM as described in material and methods, and
were exposed to RAW264.7 macrophages at 1:1 ratio. The incubation was performed in media containing the opsonizing mAb
18B7 or in its absence. As control, macrophages were preincubated with growth medium with or without the mAb. The plates
were incubated for 1h at 37˚C in the presence of 5% CO2, and then the cells were washed to remove titan-like cells. Next, C.
neoformans cells (H99-GFP) of regular size grown in Sabouraud were added to the macrophages at 1:1 ratio in the presence of
mAb 18B7, and phagocytosis was performed for 1 h at 37˚C in CO2. Phagocytosis percentage was quantified by flow cytometry as
described in M&M. ns: no statistical difference. The experiment was performed in triplicates in three different days.
https://doi.org/10.1371/journal.ppat.1007007.g010
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Fig 11. Gene expression changes by RNAseq in titan-like cells obtained in vitro. Transcriptomic profiling of the transition to titan-like cells. A) Number
of genes induced or repressed after 7 h (blue) or 18 h (red). The number of genes whose expression is modified at both times is denoted at the intersection
of the circles. Scale is only approximated. B) Gene Ontology analysis of genes induced or repressed at 7 h (upper panel) or 18 h (lower panel). All
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establishment and maintenance of chromosome condensation, and 3 out of 4 components of
the GINS complex (CNAG_03374, CNAG_02884, and CNAG_04682) which participates in
both initiation and elongation of DNA replication. Similarly, the expression of two cyclin-
encoding genes (CNAG_03385 and CNAG_00442) belonging to the G1-phase Pcl1,2 family,
was clearly repressed (Table 2). These assignations were confirmed by exploring the FunCat
classification ontology. Analysis of the repressed genes after 18 h incubation yielded two main
GO categories: genes related to transmembrane transport and to the regulation of RNA poly-
merase II promoters. In the former category there were included diverse sugar transporters
(CNAG_01862, CNAG_02733, CNAG_05662, CNAG_06292, and CNAG_06932), plus a likely
glycerol proton symporter similar to budding yeast Stl1 (CNAG_04784). The latter category
contained 14 putative transcription factors, most of them belonging to the zinc finger tran-
scriptional activator family. However, in most cases their sequence similarity with previously
characterized transcription factors was rather low, thus precluding a tentative functional
assignment.
Interestingly, several genes encoding proteins involved in Golgi-related protein traffic were
induced, specifically five out of the seven components of the COPI-coated vesicles, also known
as coatomer (α, β, β’, γ, and ε, encoded by CNAG_03554, CNAG_03299, CNAG_04074,
CNAG_01274, and CNAG_01211, respectively). COPI-coated vesicles are found associated
with Golgi membranes, are involved in Golgi to endoplasmic reticulum (retrograde) vesicle
transport, and also likely in intra-Golgi transport. The expression of components of the COPII
coat, such as CNAG_06773 (SEC24) and CNAG_04803 (SEC31), as well as that of the interact-
ing protein CNAG_00148 (SEC16) also increased. In addition, genes encoding proteins
required for cargo-selective, clathrin-dependent transport from the TNG to endosomes in
yeast were induced. These are CNAG_00977, encoding a likely homolog of the budding yeast
monomeric clathrin adaptor proteins GGA1 or GGA2, CNAG_07318, encoding the AP-1 com-
plex subunit gamma-1, CNAG_06564, coding for an AP-1 interacting protein, or the genes
coding for clathrin light and heavy chains (CNAG_04499 and CNAG_04904).
One of the genes clearly overexpressed at both 7 and 24 h encoded Calnexin
(CNAG_02500), which is a chaperone located at the ER that contributes to the proper folding
of glycoproteins. To test if this protein had any effect on titan cell formation, we obtained the
mutant and investigated its phenotype. As shown in Fig 12, in the absence of calnexin, the cells
had significantly larger size in regular rich medium compared to the wild type strain (Fig 12),
and no change was detected when the cells were transferred to TCM. This result confirmed
that calnexin was involved in processes that regulate cell size in C. neoformans.
We also noticed that some genes related to iron metabolism were also induced in titan-like
cells compared to cells of regular size. One of them (CNAG_01653) encoded Cig1, (initially
annotated as cytokine inducing glycoprotein), which is involved in iron uptake from heme
groups and is overexpressed during iron limitation conditions [46, 47]. Iron is an important
element required by yeasts, and in C. neoformans, its limitation also induces capsular enlarge-
ment. For this reason, we investigated whether iron concentration had any effect on titan-like
cell formation. As shown in Fig 13, depletion of iron using the chelator BPS induced the
appearance of cells of large size when the cultures were inoculated at high cell densities (106
cells/mL), suggesting that iron limitation also contributes to cellular enlargement.
classifications correspond to “biological function” terms, except the central graph in the lower panel, which correspond to “cellular components”. Numbers
in the histograms denote the p-value for each assignment. See Materials and Methods for details.
https://doi.org/10.1371/journal.ppat.1007007.g011
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Table 1. Genes that were significantly overexpressed (fold>2 with P<0.05) at 7 or 18 h in titan-like cells were subjected to Gene Ontology analysis. For unassigned
genes, additional Blastp comparisons against fungal data bases were carried out. T: Titan-like cells (cells incubated in TCM at 104 cells/mL); S (cells of regular size, incu-
bated in TCM at 106 cells/mL).
7h 18 h
Process Gene ID Description T/S ratio p-val. T/S ratio p-val.
Carbohydrate Metabolism
Glycolysis (p-value: 4.9E-07)
CNAG_03769 hexokinase 0.7 2.9 2.1E-05
CNAG_05480 hexokinase, variant 1.0 1.9E-03 2.6 2.5E-03
CNAG_03916 glucose-6-phosphate isomerase 0.9 3.6E-02 2.7 1.5E-04
CNAG_04676 6-phosphofructokinase 1.2 6.0E-03 2.1 2.6E-02
CNAG_06770 fructose-bisphosphate aldolase 1 0.8 2.0 2.3E-02
CNAG_02035 triose-phosphate isomerase 0.8 2.3E-02 2.1 1.4E-02
CNAG_03072 enolase (ENO1) 1.3 2.6E-04 2.2 6.5E-03
CNAG_06868 phosphopyruvate hydratase (ENO2) 0.4 3.2 3.3E-02
TCA cycle (p-value: 3.2E-04)
CNAG_00061 citrate synthase, mitochondrial 1.3 2.5E-03 2.4 1.4E-02
CNAG_03674 oxoglutarate deHase, E1 component 0.9 3.3E-02 2.3 4.4E-03
CNAG_03596 2-oxoglutarate deHase E2 component 0.6 2.0 2.4E-02
CNAG_07363 isocitrate deHase, NAD-dependent 1.0 3.4E-03 2.8 2.0E-03
CNAG_07851 isocitrate deHase, NAD-dependent 2.1 1.8E-09 2.7 5.7E-04
CNAG_05653 malate synthase A (MLS1) 1.8 2.4E-05 7.8 1.7E-11
Pentose-phosphate shunt (p-value: 5.3E-04)
CNAG_03245 glucose-6-phosphate deHase 0.6 2.8 3.2E-04
CNAG_02133 6-phosphogluconolactonase 0.6 2.6 8.7E-04
CNAG_01492 hypothetical 6-phosphogluconate deHase 0.5 2.7 1.0E-03
CNAG_04099 6-phosphogluconate deHase, decarboxylating 1.2 1.2E-02 3.3 3.8E-05
CNAG_07561 6-phosphogluconate deHase, decarboxylating 1 0.5 2.3 8.9E-03
Others
CNAG_06313 phosphoglucomutase 1.2 4.0E-04 2.7 1.9E-04
CNAG_06923 phosphoketolase 0.8 3.0 1.6E-04
CNAG_01155 glycerol kinase 1.3 6.6E-05 4.5 2.4E-06
CNAG_03113 trehalose synthase 1.1 3.7E-04 3.7 3.2E-03
CNAG_03765 trehalose-phosphatase (TPS2) 0.8 3.1 4.9E-03
CNAG_05292 α,α-trehalose-phosphate synthase (TPS1) 0.5 2.7 2.4E-03
CNAG_00373 glucan 1,3-β-glucosidase 0.3 2.0 4.7E-02
CNAG_05138 glucan 1,3-β-glucosidase 0.7 2.9 7.8E-03
CNAG_05652 glucan 1,3-β-glucosidase, putative 0.7 2.3 2.3E-02
CNAG_04033 α1,3-glucosidase 0.6 2.5 4.8E-03
CNAG_00393 1,4-α-glucan-branching enzyme 0.4 2.1 2.6E-02
CNAG_04879 glycogen debranching enzyme 0.9 2.2E-02 3.4 2.8E-05
CNAG_01164 glutamine-fructose-6-phosphate transaminase 0.9 2.2 1.6E-02
CNAG_01239 chitin deacetylase 1.5 3.3 1.9E-02
CNAG_02445 phosphoacetylglucosamine mutase 0.8 2.5 2.5E-02
CNAG_06098 glucosamine-6-phosphate deaminase 0.9 2.1E-02 2.4 6.4E-03
CNAG_06659 hexosaminidase 0.7 6.2 2.4E-06
Intracellular protein transport (p-value: 1.2E-05)
COPI and COPII vesicles
CNAG_03554 coatomer, subunit α (COP1, SEC33, RET1) 0.9 2.2E-02 2.1 6.0E-03
CNAG_03299 coatomer beta subunit (SEC26) 1.2 1.1E-03 2.4 7.8E-03
(Continued)
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Discussion
Cryptococcus neoformans is an exceptional model to understand mechanisms induced by path-
ogenic fungi to adapt to the host and cause disease. Some of the most important changes are
related to changes in cell size, which can occur by growth of the capsule, or growth of both the
cell body and capsule. In this last case, C. neoformans induces a specific cell type that has been
denominated titan cells [20, 21]. At the moment, only the cAMP-dependent and the mating
pathways have been described as relevant in titan cell formation [20, 21, 27]. It has been shown
that increased expression of PKA induces cell enlargement in C. neoformans and the ploidy of
the cells [48, 49]. One of the limitations to study titan cells is the difficulty of reproducing this
phenomenon in vitro. Originally, we described that a small proportion of titan cells could be
observed in minimal media [21]. Then, it was described that these cells appear in the presence
of phospholipids [28]. In this work, we have defined a medium in which we have consistently
replicated this phenomenon in vitro. This medium has several characteristics: limitation of
nutrients at neutral pH, inclusion of mammalian serum and a CO2 enriched atmosphere. In
these conditions, we could obtain a high proportion of cells of a size around 30 μm (capsule
included). This diameter is smaller than the average size measured in cells isolated from
mouse lungs [11, 20, 22], where average size is around 40–50 μm, so we argue that in our TCM
we could be examining the initial steps of this morphological transition. It is possible that in
vitro the cells do not reach the same size than cells obtained from in vivo infections because the
nutrients of the medium or the factors that favor this morphological change are consumed.
Instead, in vivo infections are maintained for a longer time, with a stable nutrient concentra-
tion allowing cells to reach significantly larger sizes. Despite this limitation, the availability of
in vitro conditions that, at least in part mimic titan cell formation is a key contribution to
understand the biology of these cells.
In general, our results indicate that titan-like cell formation is induced by multiple factors,
being some of them necessary, but not sufficient, to trigger the transition. This is the case of
serum which only induced cell growth under nutrient limiting conditions. These results
Table 1. (Continued)
7h 18 h
Process Gene ID Description T/S ratio p-val. T/S ratio p-val.
CNAG_04074 coatomer beta’ subunit (SEC27) 1.2 9.5E-03 2.2 1.2E-02
CNAG_01274 coatomer subunit gamma (SEC21) 1.1 1.0E-03 2.1 2.3E-02
CNAG_01211 putative coatomer subunit epsilon (SEC28) 0.7 2.0 1.5E-02
CNAG_06773 protein transporter SEC24 (SEC24) 1.2 2.9E-02 2.8 5.5E-03
CNAG_04803 protein transporter SEC31 (SEC31) 1.3 5.6E-03 2.7 7.9E-03
CNAG_00148 COPII coat assembly protein Sec16 1.1 1.8E-02 2.8 6.1E-03
clathrin-dependent transport from the TNG to endosomes
CNAG_07318 AP-1 complex subunit gamma-1 (APL4) 0.7 2.1 2.4E-02
CNAG_00977 ADP-ribosylation factor-binding protein (GGA2) 0.8 2.0 2.4E-02
CNAG_04499 clathrin light chain 0.8 2.2 8.0E-03
CNAG_04904 clathrin heavy chain 1.0 2.5E-03 2.3 5.6E-03
Others
CNAG_01653 cytokine inducing-glycoprotein Cig1 1.0 1.4E-02 3.5 2.0E-03
CNAG_00815 Siderophore-iron transporter 1.2 1.1E-03 4.4 6.3E-11
CNAG_02500 calnexin 3.1 1.0E-12 3.6 2.0E-05
https://doi.org/10.1371/journal.ppat.1007007.t001
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indicate that titan-like cells are formed in response to some elements of the host present in the
serum in the context of the stress produced by the limitation of nutrients in the medium.
These findings allow the dissection of the intracellular pathways that are triggered during cel-
lular growth.
It has been described that serum and the fraction of polar lipids induce cell enlargement in
C. neoformans. Our results agree with previous findings [28], because polar lipids were also
able to induce the formation of titan cells in TCM. The most plausible mechanism for this
effect is that phospholipids are degraded by phospholipase C, which produces diacylglycerol
(DG), or by phospholipase B, which produces arachidonic acid (AA) [50]. DG activates
human as well as C. neoformans PKC [34]. To investigate the role of this signaling pathway, we
blocked the activity of this kinase with several pharmacological inhibitors, and found that both
staurosporine and calphostine C had a dramatic effect on titan-like cell formation. This protein
participates in multiples processes, such as maintenance of the integrity of the cell wall [51–53]
and polarized growth [54]. Mutants lacking the PKC1 gene present many cellular alterations,
such as osmotic instability and susceptibility to temperature [35]. We tried to evaluate the
effect of these inhibitors at a lower temperature and in the presence of sorbitol in an attempt to
overcome the cellular defects associated with the absence of Pkc1. For this reason, further stud-
ies using mutants affected in signaling pathway components are required to understand in
detail how this pathway participates in titan-like cell formation.
We also observed that other important factor for titan-like cell formation in vitro is CO2.
The capsule is induced in response to CO2 concentrations present in the host [55], which is
consistent with this factor also favoring the growth of the cell body. Carbonic anhydrase con-
verts CO2 into HCO3
-, which activates adenylate cyclase [44, 56], so our results are consistent
with the hypothesis that CO2 induces cell growth through the cAMP pathway. In C. neofor-
mans, there are two carbonic anhydrases encoding genes, CAN1 and CAN2, with CAN2 being
the most important [44]. Interestingly, deletion of CAN1 resulted in an enhancement of the
production of titan-like cells. Although we do not know the molecular mechanism for this
phenomenon, we postulate that in the absence of Can1, there might be a compensatory overex-
pression of Can2 that could induce the hyperactivation of the cAMP pathway.
We also observed that subinhibitory concentrations of azide have a modest, but reproduc-
ible positive effect on titan-like cell development. We argue that a partial inhibition of the
respiratory chain can trigger a stress signal that results in a stop of the cell cycle and allows cel-
lular size increase. In this regard, it could be assumed that a limitation in the respiratory capac-
ity might lead the organism to generate energy, at least in part, by fermentative metabolism, a
situation that has been associated to increased PKA activity in many fungi [57]. Although C.
neoformans is mainly a respiratory yeast, it has been shown that it can produce both ethanol
and acetate in vitro and in vivo [58, 59], so a similar activation of the PKA activity could also
occur in these conditions. However, the effect of the mitochondrial inhibitor was not signifi-
cant in the presence other factors (in particular, serum and CO2). Since CO2 is an activator of
the adenylate cyclase, it is reasonable to argue that in these conditions the effect of azide would
be not significant.
One of the most striking results of this work is the effect of cell density on the formation of
titan-like cells, suggesting that this transition is regulated by quorum sensing (QS) phenomena.
In this way, a higher cell density results in a higher concentration of released molecules and
greater effect on the cells [29, 60, 61]. A major QS signal for C. neoformans is a 11-mer peptide
(Qsp1) [31, 32]. We tested the effect of this peptide on titan-like cell formation, and found that
it inhibited the transition. Qsp1 promotes cell division and replication. Although further stud-
ies are required to understand the molecular mechanism by which Qsp1 regulates this transi-
tion it is plausible to propose that, since titan-like cells are formed in the absence of budding,
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Table 2. Genes significantly repressed (>2.0-fold and p<0.05) at 7 or 18h during the formation of titan-like cells. Functional assignments were based on Gene Ontol-
ogy. For unassigned genes, additional Blastp comparisons against fungal data bases were carried out. T: Titan-like cells (cells incubated in TCM at 104 cells/mL); S (cells of
regular size, incubated in TCM at 106 cells/mL).
7 h 18 h
Process Gene ID Description T/S ratio p-val. T/S ratio p-val.
DNA Replication adn DNA Repair (p-value: 1.3E-03)
CNAG_00680 kinetochore protein Nuf2, variant 0.1 3.6E-04 0.4 6.9E-03
CNAG_00681 condensin complex subunit 3, variant 0.2 6.7E-03 0.6
CNAG_00991 flap endonuclease 1 0.1 2.4E-03 0.7
CNAG_01144 replication factor A1 0.3 4.1E-02 0.8
CNAG_01430 hypothetical protein 0.1 2.8E-03 0.6
CNAG_01916 DNA mismatch repair protein Msh6 0.3 4.8E-02 0.6
CNAG_01959 condensin complex subunit 1 0.2 1.3E-02 0.4 6.6E-03
CNAG_02491 nuclear protein 0.1 3.4E-02 0.2 2.4E-03
CNAG_02884 DNA replication complex GINS protein Psf2 0.2 2.8E-02 0.7
CNAG_02963 anaphase-promoting complex subunit 8 0.1 2.6E-02 0.4
CNAG_03148 nuclear condensin complex protein 0.2 2.5E-02 0.5 4.6E-02
CNAG_04231 hypothetical protein 0.2 3.9E-02 0.5
CNAG_04682 DNA replication complex GINS protein Psf3 0.1 6.5E-04 0.2 4.5E-03
CNAG_05177 DNA polymerase kappa subunit 0.1 6.0E-04 0.3 3.4E-03
CNAG_05468 AP endonuclease 1 0.2 3.2E-02 0.4
CNAG_05891 TDG/mug DNA glycosylase 0.2 2.9E-02 0.8
CNAG_06273 hypothetical protein 0.2 2.8E-02 0.5
CNAG_06588 hypothetical protein, variant 0.2 3.9E-02 0.5
CNAG_06634 DNA polymerase epsilon subunit B 0.2 1.5E-02 0.5
CNAG_06793 exonuclease 1 0.2 2.6E-02 0.6
CNAG_07657 U3 small nucleolar RNA-associated protein 19 0.2 4.6E-02 0.5
Ribosome biogenesis (p-value: 1.1E-03)
CNAG_01104 ribosomal RNA-processing protein 8 (RRP8) 0.2 7.3E-04 0.5
CNAG_01550 pre-rRNA-processing protein (TSR3) 0.1 6.1E-04 0.5
CNAG_01715 ribosome biogenesis protein (BMS1) 0.2 1.2E-02 0.7
CNAG_01812 large subunit ribosomal protein L24e 0.2 4.8E-02 0.4
CNAG_02672 nonsense-mediated mRNA decay 3 (NMD3) 0.2 2.5E-02 0.5
CNAG_03724 ribosomal RNA methyltransferase Nop2 0.3 3.3E-02 0.5
CNAG_03954 ribosomal RNA-processing protein 17 0.2 1.9E-02 0.4
CNAG_04259 H/ACA ribonucleoprotein complex subunit 1 0.2 4.5E-02 1.0
Transmembrane transport (p-value: 4.8E-6)
CNAG_00726 Allantoate permease (DAL5) 0.0 0.0 3.4E-02
CNAG_00898 multidrug efflux pump, YOR378W-related 0.1 0.0 4.9E-03
CNAG_00904 aflatoxin efflux pump Aflt 0.1 0.0 7.5E-03
CNAG_01118 putative dicarboxylic amino acid permease 0.1 1.0E-03 0.2 4.2E-02
CNAG_01545 hypothetical protein, variant 0.2 0.3 3.3E-02
CNAG_01862 hexose transporter (STL1,HXT8,HXT13,. family) 0.3 0.2 4.7E-02
CNAG_02595 hypothetical protein, variant 0.1 2.7E-02 0.2 1.5E-02
CNAG_02733 hexose transporter (STL1,HXT8,HXT13,. family) 0.3 0.0 6.9E-03
CNAG_02777 Pi transporter PHO84 0.4 0.5 1.4E-02
CNAG_04567 putative TPO-related spermine transporter 0.2 0.3 2.8E-02
CNAG_04597 hypothetical protein 0.2 0.3 1.8E-02
CNAG_04784 Sugar transporter (STL1, SNF3 family) 0.1 0.2 3.3E-02
CNAG_04794 spermine transporter (TPO2, TPO3 family) 0.2 5.3E-04 0.5 4.4E-02
(Continued)
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Qsp1 blocks this development due to its positive effect of cell division and replication. The bio-
logical role of QS phenomena on titan-like cells is not known. However, it is worth noting that
a cell-dose relationship similar to that found here has been described in vivo, since a low num-
ber of cryptococcal CFUs in the lung correlates with a higher proportion of titan cells [21].
Therefore, it will be necessary to elucidate the role of Qsp1 in the context of lung colonization
in the future. However, this peptide does not seem to be the only factor that represses cellular
growth at high densities, since qsp1mutants form titan-like cells similarly to the wild type
strain. In agreement with this notion, C. neoformans produces QS molecules that are not sus-
ceptible to high temperature, proteinase, trypsin, pronase, DNAse, RNAse and glucosidase
[30]. These authors also described that farnesol, tyrosol and Qsp1 did not replicate the effects
observed with their conditioned media, and demonstrated that pantothenic acid could in part
reproduce QS phenomena. In summary, we hypothesize that several QS molecules negatively
regulate titan-like cell formation.
The formation of titan cells has been observed in clinical samples [62–64], and despite
being a mechanism that confers advantages to C. neoformans against the host during infection,
Table 2. (Continued)
7 h 18 h
Process Gene ID Description T/S ratio p-val. T/S ratio p-val.
CNAG_04818 MFS monocarboxylate transporter, putative 0.1 2.2E-02 0.2 2.4E-02
CNAG_05662 hexose transporter (HXT8,HXT13, HXT17 family) 0.1 1.2E-02 0.3 2.2E-02
CNAG_05867 L-fucose permease, putative 0.2 0.2 1.1E-05
CNAG_05992 Allantoate permease 0.1 0.0 1.9E-02
CNAG_06102 ADP,ATP carrier protein, variant 1 0.1 6.6E-05 0.2 7.5E-03
CNAG_06292 sugar transporter 0.1 0.2 2.5E-02
CNAG_06557 N-acetylglucosamine-specific transporter 0.6 0.0 3.2E-03
CNAG_06561 allantoate transporter 0.0 0.0 2.6E-02
CNAG_06758 multidrug efflux pump, YOR378W-related 0.3 0.2 2.9E-04
CNAG_06932 sugar transporter (STL1,HXT17, HXT13 family) 0.2 0.2 6.7E-03
CNAG_07449 General amino acid permease (AGP2) 0.1 0.2 2.8E-02
https://doi.org/10.1371/journal.ppat.1007007.t002
Fig 12. Phenotype of the mutant lacking calnexin (cne1). Pictures of the WT (KN99 strain,A) and a cne1mutant (lacking calnexin,
CNAG_02500, B) in liquid Sabouraud medium. The scale bars denote 20 μm. (C) Measurement of cell body size of the WT strain
(KN99) and the mutant lacking calnexin. The cells were incubated in liquid Sabouraud at 30˚C or TCM (overnight) at 37˚C with 5%
CO2.
https://doi.org/10.1371/journal.ppat.1007007.g012
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we observed that this process is not a universal phenotype. Our results showed that there is
great variability among different isolates, and not all the strains did form titan-like cells in
vitro. Our work provides a new way to investigate the genetic differences between strains with
high and low capacity to form titan-like cells using genomic approaches. However, the strains
of C. neoformans var. grubii (serotype A) exhibited the highest proportion of titan-like cells,
suggesting that this serotype has a greater capacity of adaptation to the lung. This result is in
agreement with the literature, since this serotype is the one most frequently isolated in infected
patients [10], suggesting that there is a correlation between the ability to form titan cells and
development of the disease. We believe that this correlation should be confirmed in future
clinical studies.
Previous reports demonstrate that during capsule growth, the size of this structure corre-
lates with cell body size [65]. In addition, capsule growth mainly occurs in G1 [66], which is
also the cell cycle phase in which the growth of the cell body occurs. However, although titan-
like cells increased capsule thickness, the size of this structure was significantly smaller than
the one found in titan cells isolated from animals, indicating that the process that occurs in
vitro is, at least quantitatively, not fully equivalent to the one observed in vivo. We argue that
the phenomenon that we observed in vitro in this work describes the first steps of titan cell for-
mation. In addition, it is reasonable to argue that when the cell body enlarges significantly,
there could be a metabolic limitation affecting the growth of the capsule, since its volume
increases with the cube value of the radius.
Titan cells contribute to virulence through different mechanisms, such as polarization of
Th2-type immune responses [23, 24], replication [26, 67], resistance to oxidative damage [20,
21] and phagocytosis avoidance [21, 25]. In our case, titan-like cells obtained in vitro were not
phagocytosed, most probably due to their large size. In our case, these cells did not prevent the
phagocytosis of cryptococcal cells of regular size, as it is the case in experiments performed in
vivo [25]. We believe that activation of the macrophages in vivo is different from in vitro, so in
the lungs there could be multiple factors that affect the phagocytic activity of macrophages,
explaining why the effect of titan cells in vivo on macrophages are not identical from the effects
induced in vitro. Furthermore, it is also possible that titan cells in vivo express virulence factors
or epitopes that are not produced in vitro. Further studies are required to fully understand the
response of immune cells to cryptococcal titan-like cells.
Fig 13. Effect of iron chelation on cryptococcal morphology. The effect of iron chelation on cell body size was
observed by the supplementation of TCM with the iron chelator Bathophenanthroline disulfonic acid (BPS) in TCM
cultures inoculated at 104 cells/mL cultures (A) and 106 cells/mL cultures (B). The cells were incubated at 37˚C
overnight with 5% CO2 without shaking. CT, control cells without BPS.
https://doi.org/10.1371/journal.ppat.1007007.g013
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The isolation of titan-like cells in vitro opens new perspectives and research lines. For exam-
ple, we investigated gene expression changes associated with titan cells development. In our
approach, we compared cells of different size incubated in the same medium (TCM), so the
cells were exposed to the same nutritional environment and inducing factors (CO2 and
serum). The difference in cell size was obtained due to the different initial cellular density of
the cultures (104 vs 106 cells/mL). In this way, our approach would also detect those changes
due to quorum sensing phenomena. Despite the cells were incubated in the same medium, we
detected changes in many genes involved in metabolism at both times (7 and 18 h). This sug-
gests that the increase in cell size requires a metabolic adaptation that allows the efficient use
of extracellular and intracellular sources of nutrients. The induction of many genes involved
glycolysis and TCA cycle suggest a higher demand of energy, whereas the increase in the
expression most of the components of the oxidative branch of the pentose phosphate shunt
(including glucose-6P dehydrogenase, which catalyzes the rate-limiting step) suggest an
increased need for NADPH, a requirement for anabolic biosynthetic pathways. Such require-
ment could be explained by a higher demand for fatty acid synthesis to provide structural com-
ponents for an increasing membrane surface. Alternatively, it could be considered that
induction of a large number of metabolic enzymes would be simply required to maintain its
normal concentration in response to a growing cellular volume.
Our results also highlight other processes that might be involved in titan cell formation. In
particular, we found that several genes encoding components of COPI and COPII vesicles,
which belong to the coatomer complex. These proteins cover the surface of vesicles involved in
intracellular protein sorting and early secretory pathway. Interestingly, we found that clathrin-
encoding genes were also induced. Although we do not know how these proteins contribute to
cryptococcal cellular enlargement, we argue that titan cells might recycle, import and export
proteins at a higher rate than regular cells. Interestingly, we also found that the expression of
genes encoding some chaperones, such as calnexin, involved in folding of glycosylated proteins
increased in titan-like cells, and mutants lacking this protein have an abnormal large size, even
in regular rich medium. This result was somehow unexpected, because the expression of this
gene increased in titan-like cells. In consequence, we argue that calnexin plays a role, not only
in proper folding of glycosylated proteins, but also regulates cell size in conditions of active
protein synthesis and replication. In addition, it is possible that it absence results in an stress
signal that results in cell cycle changes and G1 arrest, that would produce an increase in cell
size too. In this sense, mutants lacking Atg7 (which is part of the ubiquitin-activating enzyme
(E1) family and is required for proper authophagy [68]) have also increased cell size and higher
DNA content, supporting the idea that titan formation is affected by the trafficking and recy-
cling of intracellular proteins.
Our results indicated that iron depletion from the medium can also regulate the induction
of titan-like cells. Interestingly, iron limitation also induces the growth of the cryptococcal cap-
sule [69]. Iron is an important cofactor required for multiple enzymatic activities, so its
absence is an important stress signal that results in the expression different acquisition mecha-
nisms, involving siderophores, Cig1 and transporters [70]. Our findings are in agreement with
the idea that titan-like cell formation is a response to nutritional stress.
Titan cells isolated from mice are polyploid, so presumably the factors and signaling path-
ways must alter the normal progression of cell cycle. Interestingly, we found that in titan-like
cells, genes related to DNA replication were repressed. In agreement, G1/S cyclins, like Pcl1,
were repressed, which suggests that the process requires an elongation of the G1 phase. This
result is in agreement with previous findings that demonstrated that pcl1mutants have
increased capacity to form titan-like cells in vivo [27]. In our titan-like cells, we found that they
have a higher content of DNA compared to cells of regular size. However, the DNA content of
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titan-like cells is lower than the content in titan cells isolated from mice, indicating that cell
cycle changes that occur in vitro are different from in vivo.
Finally, we would like to acknowledge that other groups (Dr. Alanio, Pasteur Institute,
France, and Dr. Ballou, University of Birmingham, UK) have identified in parallel to our work
other conditions in which titan-like cells are formed. We believe that these works together
with our findings provide significant advances to the scientific community because they will
allow the design of multiple research lines that will facilitate the characterization of the factors
and signaling pathways that are involved in titan cell development. The data presented by dif-
ferent groups also indicate that C. neoformans may induce titan-like cells in vitro in response
to multiple factors. In addition, the ability to obtain titan cells in vitro will also have a positive
bioethical impact because we will be able to significantly reduce the number of experimental
animals compared to what was required previously to characterize these cells.
Material and methods
Strains and media
In most of the experiments, we used C. neoformans var. grubii (serotype A) H99 strain [71],
but we also included C. neoformans var. neoformans (C. deneoformans, serotype D), A/D
hybrids and C. gattii, and different mutants obtained from the library described by Liu and
coworkers [41] and from the Fungal Genetic Stock Centre. All strains are described in Table 3.
Strains were preserved in Sabouraud medium containing 30% glycerol at -80% and were
recovered at 30˚C in Sabouraud solid medium (Oxoid LTD, UK).
In order to delete the CNE1 (CNAG_2500), a gene a disruption cassette was constructed by
overlapping PCR [72] using PCR fragments amplified from either the plasmid pHYG (kindly
given by Prof. Jennifer Lodge, Washington University in St Louis, USA) or genomic DNA
extracted from the strain KN99α [73].
The C. neoformans strain KN99α was then transformed by biolistic delivery [74] and trans-
formants were screened on YPD medium containing 200 U ml-1 of hygromycin (Calbio-
chem). The correct deletion of the gene was tested using primers within and outside the
cassette. Finally, the absence of additional ectopic integration of the cassette was checked by
Southern blot experiment. Two independent cne1Δ::HYG strains (NE375 and NE376) were
selected for further studies.
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The yeasts were routinely grown in liquid Sabouraud medium at 30˚C or 37˚C with shaking
(150 r.p.m.). To induce titan-like cells, strains were grown in a medium that we have defined
as Titan Cells Medium (TCM), which is based in the medium described to induce capsule
growth (10% Sabouraud buffered at pH 7.3 with 50 mM MOPS, [75]). TCM contains 5%
Sabouraud and 5% inactivated fetal calf serum (FCS, Biological Industries) diluted in MOPS
50 mM at pH 7.3 plus 15 μM sodium azide (Sigma Aldrich). Cultures were grown in tissue cul-
ture flasks or 96-wells plates at 37˚C in an atmosphere enriched with CO2 for 18 hours. For
iron depletion different concentrations of bathphenanthroline disulfonate (BPS, Sigma
Aldrich) were prepared directly in TCM. Cells were then inoculated at 104 or 106 per mL and
incubated at 37˚C with 5% CO2 for 18 hours.
Table 3. List of strains used.
Species Strain Reference or Source
C. neoformans
var. grubii
(C. neoformans, serotype A)
H99 [71]
CL-5659 Mycology Reference Laboratory (CNM)
3259 KN99 (MATa) Institut Pasteur








cap60 Obtained from collection described in [41]
qsp1 [32] obtained from FGSC
ada2 [42] obtained from FGSC
C. neoformans
var. neoformans
(C. deneoformans, serotype D)
ATCC 24067 American Type Culture Collection
B3501 [83]
CL-6435 Mycology Reference Laboratory (CNM)
CL-6760 Mycology Reference Laboratory (CNM)
JEC20 (MATa) [84]
JEC21 (MATa) [84]
NE 822 (MATa) [85]




CL-4041 Mycology Reference Laboratory (CNM)
CL-4840 Mycology Reference Laboratory (CNM)
CL-5706 Mycology Reference Laboratory (CNM)
CL6434 Mycology Reference Laboratory (CNM)
C. gattii NIH 191 NIH, Bethesda, Maryland
NIH 198 NIH, Bethesda, Maryland
CBS-10514 (R265) [40]
CBS-10865 (R272) [40]
For clarity, we have specified the different suggested nomenclatures for the Cryptococcus species complex, specifying
the varieties, serotypes and species name. In the case of C. gattii, we preferred to use the classical nomenclature that
groups all the genotypes, serotypes and species because we did not include different strains from all these different
groups.
https://doi.org/10.1371/journal.ppat.1007007.t003
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India Ink staining and measurement of cell size and capsule permeability
To observe and measure the size of the cells, 10 μL of a cell suspension were mixed with a drop
of India Ink drop (Remel Bactidrop, Lenexa, Kansas) and observed under a Leica DMI 3000B
microscope. Pictures were taken with a Leica DFC 300FX camera using the Leica Application
Suite (Leica Microsystems) and processed with Adobe Photoshop 7.0 (San Jose, CA) or ImageJ
(https://imagej.nih.gov/ij/) [75]. In some experiments, the permeability index was measured
using fluorescently-labeled dextrans as described in [67].
Infections of mice with C. neoformans and yeast isolation from lungs
Six to eight weeks-old male mice from C57BL/6J (in house bred at the National Centre for
Microbiology) were used in all experiments. The animals were kept in ventilated racks at 22–
24˚C with proper environmental enrichment (cupboard houses and hollow cylinders).
Yeast cells were incubated overnight in liquid Sabouraud medium at 30˚C, centrifuged at
2830 g, washed and suspended in sterile PBS. The cell density was determined using a TC20
cell counter (BioRad) and a suspension of 3.3x107 cells/mL was prepared in sterile PBS. The
animals were anesthetized with a mixture of ketamine (Imalgene 1000, 50 mg/Kg) and xylazine
(Xilagesic 2%, 20 mg/Kg) and infected intranasally with 30 μL of the yeast suspension (106
cells per mouse) as previously described [23]. Animals were sacrificed after 14 days of infection
by exposure to a high CO2 enriched environment.
We excised and homogenized the lungs in 10 mL of sterile water using cell strainers
(100 μm size pore, BD Falcon) and a 5 mL syringe plunge in Petri plates. This process disrupts
the mammalian cells without significantly affecting the integrity of the cryptococcal cells. Then
the cell suspension was centrifuged at 2,830 g and washed with sterile water three times to fully
break and remove the mouse cells. Finally, the yeasts were suspended in PBS.
Lipids extraction of fetal bovine serum (FBS)
Polar lipids from serum were obtained as described in [28]. Briefly, aliquots of 1 mL of FBS
were shaken with a mixture of chloroform and methanol (2:1) (v:v) for 3 hours at room tem-
perature. The samples were centrifuged for 10 minutes at 2,830 gs for phase partitioning. The
upper phase was collected in a 1.5 mL tube and dried during 1 hour in a SpeedVac concentra-
tor. The pellet was suspended in 200 μL of PBS and conserved at 4˚C. To evaluate the effect of
serum polar lipids on titan-like cell formation, we performed experiments with different
amounts of the extraction solution described above (1/40; 1/100 and 1/200 dilution) in 5%
Sabouraud buffered at pH 7.3 with 50 mM MOPS and 15 μM sodium azide. As a control, the
same medium with PBS was used. In parallel, cells were grown in Sabouraud and TCM as
growth control and titan-like cell formation respectively.
To evaluate the role of phosphatidylcholine (Sigma Aldrich), a 20 mM stock of this phos-
pholipid was prepared in EtOH 100%. Then, 1/10 dilutions were done in distilled water to
yield 0.1, 0.01 and 0.001 mM (final concentration) in TCM without serum. Same dilutions of
EtOH 100% were added to the medium as control.
Visualization of titan-like cell formation by real-time microscopy
Yeast cells were inoculated in TCM at 104 cells/mL as detailed above. One hundred seventy μL
from the yeast suspension were placed in a 96 well plate and incubated at 37˚C with 5% CO2
under a Leica DMI 4000B microscope. Photographs were taken every 3 min using the 20x
objective. The videos generated by the Leica software were exported as AVI documents and
processed with ImageJ software. In all cases, the videos were assembled with 12 frames per
In vitro characterization of titan-like cells in Cryptococcus neoformans
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007007 May 18, 2018 27 / 37
second, so one second of video corresponds to 36 minutes of real time. Time was included in
each frame using the Time Stamper plugin from ImageJ.
Effect of conditioned media and Qsp1 on titan-like cell formation
Cell suspensions were prepared at a concentration 106 cells/mL in parallel in Sabouraud with
15 μM sodium azide and TCM. Serial 1/10 dilutions were made up to 103 cells/mL. A volume
of 170 μL of these suspensions was incubated in a 96 well plate at 37˚C overnight with 5% CO2
without shaking. The plates were observed with a Leica DMI 3000B microscope. Pictures were
taken with a Leica DFC 300FX camera using Leica Mycrosystems software. The cell body
diameter of thirty to fifty cells was measured with Adobe Photoshop 7.0.
Cryptococcus neoformans was inoculated at 104 and 106 cells/mL in TCM as described
above and incubated at 37˚C in a 5% CO2 enriched atmosphere. After 18 h of incubation, the
cultures were centrifuged and the supernatants collected to yield Titan-like Cell Supernatant
(TCS) and regular cells supernatant (RCS). To evaluate the influence of these supernatants on
the titan-like cell formation, C. neoformans cultures inoculated at 104 cells/mL in 96 wells
plates were prepared in different growth conditions: 1) Fresh TCM medium (TCM), 2) Super-
natant from cultures of titan-like cells (TCS), 3) Supernatant from cultures of cells of regular
size (RCS). These conditioned media were mixed with fresh TCM (1:1 proportion v/v). As
control, we carried out a culture in which fresh TCM was diluted with the same volume of dis-
tilled sterile H2O. After the inoculation of the different media and mixtures with C. neoformans
at 104 and 106 cells/mL and incubation at 37˚C in a CO2 incubator for 18 h, the cell size was
measured by microscopy as described above.
Chemical synthesis of the peptides was done by the proteomic facility of the National Cen-
tre for Biotechnology (CSIC, Spain) using an Multipep automatic synthesizer (Intavis, Köln,
Germany) and Fmoc-Amino Acid Wang resins (Merck, Darmstadt, Germany). After release
from the resin, the peptides were purified by reverse-phase chromatography in a semiprepara-
tive HPLC system (Jasco, Tokio, Japan) with a C18 Kromaphase column (Scharlab, Barcelona,
Spain). The fractions were analyzed by mass spectrometry and lyophilized until their use. We
synthesized peptides described in [32]: Qsp1 (NFGAPGGAYPW), an inactive version of this
peptide (NFGAPGAAYPW) and a scrambled Qsp1 peptide (AWAGYFPGPNG). The peptides
were dissolved in sterile PBS at 1 mM, and their effect on titan-like cell formation was tested at
30 μM and 15 μM in TCM. The samples were incubated for 18 hours at 37˚C with 5% of CO2
in 96 wells plates. After the incubation period, the cells were observed by optical microscopy
and the body cell sizes were measured.
Nuclei analysis in titan-like cells
Cryptococcus neoformans cells from H99 strain were cultured overnight in TCM at 104 and 106
cells/mL at 37˚C with CO2 without shaking. After the confirmation of titan-like cell formations
by optical microscopy, cells were washed with dH2O and fixed with 70% ethanol at 24˚C for
one hour followed by an overnight incubation at 4˚C. After fixing, the cells were washed twice
with RNAse A buffer (0.2 M Tris, pH 7.5, 20 mM EDTA) and treated with 10 μg/mL of RNAse
A for 4 hours at 37˚C. After the incubation, cells were washed twice with PBS, suspended in
PBS and incubated overnight at 4˚C. Next day, the cells were centrifuged and suspended in a
200 ng/mL solution of 4’,6-diamidino-2-phenylindole (DAPI) and incubated in the dark for
10 minutes at room temperature to stain the nucleus. Then, the cells were washed, suspended
in PBS and the fluorescence intensity of the nucleus were analyzed by flow cytometry. Cells
were examined for cell size by forward scatter parameter (FCS) and granularity by side scatter
parameter (SSC) using the BD LSRFortessa X-20 cytometer (BD, Bioscience). Two populations
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of titan-like and regular cells were delimited and, in each population, the fluorescence intensity
of the DAPI staining in 10,000 cells was measured. Data obtained were analyzed with the BD
FACSDiva (BD, Bioscience) and FlowJo 10.4.2 (Tree Star Inc, Ashland, Oregon) softwares.
The nuclei of the C. neoformans H99 titan-like and regular cells stained with DAPI were also
observed by conventional fluorescence in a Leica DMI3000B microscope and confocal micros-
copy using a Leica SP5 confocal microscope.
Influence of the protein kinase C (PKC) inhibitors and rapamycin on the
formation of titan-like cells
The influence of the PKC pathway in the formation of the titan-like cells was evaluated by the
addition of four different inhibitors: calphostin C, staurosporine and bisindolylmaleimide I,
and genistein (all from Calbiochem) that inhibits tyrosine kinase as a control. For this purpose,
10 μM, 5 μM and 1 μM of calphostin C, bisindolylmaleimide I and Genistein and 0.01 μM and
0.001 μM of staurosporine. In all cases, the final concentration of DMSO was 0.1%, which did
not inhibit titan-like cell formation.
Phagocytosis of titan-like cells in vitro with RAW 264.7 macrophages
RAW 264.7 macrophages were maintained in DMEM medium supplemented with heat-
inactivated 10% fetal bovine serum (FBS, Hyclone-Perbi), 10% NCTC medium and 1%
non-essential amino acids (Sigma-Aldrich, Steinheim, Germany). The day before the exper-
iment, the macrophage monolayer was separated from the plate by pipetting and the cells
were centrifuged at 1,265 g. Macrophage suspensions were prepared at 2.5x105 cells/mL.
Two hundred μL per well were inoculated into 96 well plates and incubated overnight at 37˚
C and 5% CO2. The next day, different types of cells (titan-like cells obtained in vitro, and
cells of regular size) at a final concentration of 5x105 cells/mL with 5 μg/mL of monoclonal
antibody 18B7 [76] were added to the macrophages for 2 hours. Phagocytosis was quantified
by two different methods. First, the plates were observed with a Leica DMI 3000B micro-
scope, and the percentage of infected macrophages was determined visually. In some cases,
the plate was visualized with a Leica 4000B with a chamber that allowed incubation at 37˚C
and 5% CO2, and videos were taken as explained above. Alternatively, we quantified the
phagocytosis percentage by flow cytometry. In this approach, we performed phagocytosis
assays as above, but using larger volumes in 24-well plates containing 1 mL of medium. To
differentiate yeast cells, we used a H99 strain that expresses the green fluorescence protein
(H99-GFP) [77]. In some experiments, macrophages were exposed for 1 h to titan-like cells
(H99 strain, 1:1 ratio) with mAb 18B7. As control, macrophages were also preincubated
with the same cells, but without mAb, and also with medium alone (with and without
mAb). Then, the wells were washed with fresh medium, and cryptococcal cells of regular
size (H99-GFP, grown overnight in Sabouraud at 30˚C) were added at 1:1 ratio for 2 h.
After the incubation, we washed the plates, and separated the macrophages by continuous
pipetting. The cell suspensions were washed and suspended in PBS containing 1% FCS.
Macrophages were blocked with anti-Fc mAb (2.4G2, BD Biosciences, 5 μg/mL) for 10 min
at 4˚C. After that, the macrophages were washed with PBS/FCS, and then incubated with an
anti-Mac1 mAb (anti-CD11b/Mac1-PE/Cy7, BioLegend, 1 μg/mL) for 20 min at 4˚C in the
dark. Finally, the cells were washed and suspended in 4% p-formaldehyde prepared in PBS.
The cells were analyzed in a FACS Canto cytometer (Biosciences, California, EEUU) using
FASCDiva software (versión 6.1). The phagocytosis percentage was calculated as followed:
(number of PE-Cy7+/GFP+)/(total number of the PE/ PE-Cy7+ cells)100. Experiments
were performed in triplicate in three times on different days.
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Confocal microscopy
In some experiments, cryptococcal cells were labeled with mAb 18B7 labeled with Alexa-488
[78] at 1 μg/mL to label the capsule, and calcofluor (10 μg/mL, Sigma Aldrich) to label the cell
wall. The cells were incubated for 1 h at 37, and then, they were washed and observed in a con-
focal SP5 Leica microscope.
RNA preparation for RNASeq and transcriptomic data analysis
RNA extraction was performed using Trizol (TRI Reagent, Sigma Aldrich) with some modifi-
cations. After incubation of the cells, Trizol was added to the samples immediately and main-
tained in ice. Cells were broken during 5 minutes with FastPrep -24 (MPTM), alternating 20
seconds beating with 1 minute on ice. The RNAs concentration and quality was determined
with a Nanodrop 8000 Spectrophotometer (Thermo scientific). RNA samples (0.1 μg/μL) were
treated with DNase using the DNA-free kit (Thermo Fisher Scientific). Then, the RNA samples
were purified using RNeasy Mini Kit (Qiagen).
Total RNA samples (0.5–1 μg) were treated to remove rRNA using Ribo-Zero Magnetic Kit
(Epicentre, Illumina, San Diego, CA) according to the manufacturer’s instructions. Then,
mRNA was processed for library preparation using ScriptSeq v2 RNA-Seq Library Preparation
kit (Epicentre, Illumina, San Diego, CA). Libraries were quantified using the QuantiFluor
RNA System (Promega) and the quality and average size was determined using an Agilent
2100 Bioanalyzer. An Illumina NextSeq 500 High Output (400 M reads, 1x75 cycles) was using
for sequencing. The FastQ files generated by the equipment were analyzed for low quality
reads and those with Q<30 were removed. Original FastQ documents were uploaded to GEO
repository (series record GSE111400). Mapping was carried out with the Bowtie2 software
[79] using the C. neoformans var. grubii H99 genome as reference. The SAM files generated by
Bowtie2 were analyzed using the software SeqMonk v0.39.0 (Babraham Bioinformatics). Three
biological replicates for cells treated for 7 h (comprising 8.3 to 9.5E+06 reads each) and two for
18 h (6.9 and 7.9E+06 reads each) were combined, subjected to the RNA-Seq pipeline and eval-
uated for differential expression using the DESeq2 algorithm [80] with a FDR of p<0.05. The
products of this test were recovered as Annotated Probe Report, which included the coding
sequences (overlapping option), and processed in Excel format. To identify functional families
significantly overrepresented among the differentially expressed genes, the lists of genes was
submitted to Gene Ontology (GO) and FunCat analyses at the FungiFun server (https://elbe.
hki-jena.de/fungifun/fungifun.php) [81]. To this end, unless otherwise stated, a Fisher’s exact
test with significance level set to 0.05 and the Benjamini-Hochberg adjustment method were
used. Due to the large number of cryptococcal gene products lacking functional annotation in
the databases, a Blastp search was conducted against the proteomes of several different, rela-
tively well-annotated fungi, in order to expand the available functional information on the rel-
evant genes.
Ethics statement
All the animal procedures were approved by the Bioethical Committee and Animal Welfare of
the Instituto de Salud Carlos III (CBA2014_PA51) and of the Comunidad de Madrid (PROEX
330/14) and followed the current Spanish legislation (Real Decreto 53/2013).
Statistical analysis
Statistical analysis was performed with GraphPad Prism 5. Before comparison among groups,
the normality of each simple was assessed using the Kolmogorov-Smirnov test (non-normal
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distribution when p<0.1). When normal distribution was assumed, differences were estimated
using ANOVA and T-Student. For non-parametric distributions, the Kruskal-Wallis and
Mann-Whitney tests were used. Statistical significant is highlighted with asterisks in the figures
as follows: p>0.05, not significant (ns); p<0.05 and>0.01 (); p<0.01 and p>0.001 ();
p<0.001 and p>0.0001 (); p<0.0001 ().
Supporting information
S1 Fig. To confirm nuclear analysis, we also used the C. neoformans strain SL305 Kn99α
NOP1-mCherry [33] that express the nucleolar protein Nop1 tagged with mCherry. In this
case, we prepared suspensions of C. neoformans cells at 104 and 106 cells/mL in 30 mL of TCM
cell. After the incubation period, the cells were collected by centrifugation, fixed with 4% p-
formaldehyde and analyzed by flow cytometry using the BD LSRFortessa X-20cytometer (BD,
Bioscience). Two populations of titan-like and regular cells were delimited and, in each popu-
lation, the fluorescence intensity of the NOP1-mCherry protein in 10,000 cells was measured.
Data obtained were analyzed with the software BD FACSDiva (BD, Bioscience) and FlowJo
7.6.1 software (Tree Star Inc, Ashland, Oregon). Nuclei of the C. neoformans SL305 titan-like
and regular cells were also observed by confocal microscopy using a Leica SP5 confocal micro-
scope. In this case, cells were stained with mAb 18B7 conjugated to Alexa-488. A) Titan-like
cells; B) cells of regular size. C. Histogram analysis of the NOP1-mCherry fluorescence inten-
sity from cells of regular size (blue) or titan-like cells.
(TIF)
S2 Fig. Effect of mixture of a and α strains on titan-like cell formation. Cells from different
a and α pairs (A, 3259/3260; B, JEC20/JEC21; and C, NE822/NE824) were placed in TCM at
104 cells/mL. In addition, parallel cultures in which the medium was inoculated with a mixture
of same amount of cells (yielding a 104 cells/mL concentration too) of both mating types were
examined. The plates were incubated at 37˚C with 5% CO2 without shaking for 18 h. Then,
pictures were taken, and the size of around 50–100 cells was measured and plotted.
(TIF)
S3 Fig. Cells grown in liquid Sabouraud or incubated in TCM at 106 cells/mL or 104 cells/
mL (titan-like cells) were labeled with mAb 18B7 conjugated to Alexa-488 to visualize the
capsule, and with calcofluor white to stain the cell wall (see Material and Methods). Then,
the cells were observed in a confocal microscope, and brightfield and fluorescence images
were taken. The bars denote 10 microns in all pictures. At the right panel, cells grown and
labeled in the same way were analysed by flow cytometry to quantify the fluorescence intensity
of the mAb. The corresponding dot plots and fluorescence histograms are shown. In the histo-
grams, the fluorescence of control cells (without mAb) or with mAb Alexa-488 (18B7) are
shown with arrows. The fluorescence image and cytometry analysis for each sample are
aligned in the same rows.
(TIF)
S1 Video. Cells in Sabouraud medium at 37˚C. Videos were obtained as described in Mate-
rial and Methods. Pictures were taken every 3 minutes, and video was assembled at 12 frames
per second, so one second of video corresponds to 36 minutes of real time. Time in each frame
reflects the incubation time in TCM.
(AVI)
S2 Video. Development of titan-like cells. The yeasts were inoculated in TCM at and incu-
bated overnight at 37˚C with 5% CO2. Previous to the start of the acquisition, the cells had
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been in TCM for 8 h, so the time shown in each frame reflects the total incubation time since
the cells were placed in TCM. Videos were assembled as described in S1 Video.
(AVI)
S3 Video. Intracellular features in titan-like cells. Previous to the start of the video, the cells
had been in TCM for 7h 30 min, so the time shown in each frame reflects the total incubation
time since the cells were placed in TCM. Images were collected and processed as described
above.
(AVI)
S4 Video. Phagocytosis of titan-like cells by RAW264.7 macrophages. Videos of the interac-
tion between titan-like cells and macrophages were performed as described in Material and
Methods. Arrow highlights a titan-like cell. Time in the upper right part reflects the time since
the beginning of the phagocytosis in minutes.
(AVI)
S5 Video. Phagocytosis of cells of regular size obtained in TCM by RAW264.7 macro-
phages. Cryptococcal cells were incubated in TCM at a cell density of 106 cells/mL, and after
one night of incubation at 37˚C with 5% CO2, phagocytosis was performed as described in
material and methods. Arrow highlights phagocytosis events. Time in the upper right part
reflects the time (min) since the beginning of the phagocytosis.
(AVI)
S6 Video. Phagocytosis of cells of regular size obtained in Sabouraud by RAW264.7 macro-
phages. Cryptococcal cells were incubated in liquid Sabouraud and after one night of incuba-
tion at 37˚C with 5% CO2, phagocytosis was performed as described in Material and Methods.
Arrow highlights phagocytosis events. Time in the upper right part reflects the time since the
beginning of the phagocytosis in minutes.
(AVI)
S1 Table. List of genes induced during titan-like cell formation. Gene expression changes in
titan-like cells isolated in vitro. Titan-like cells were obtained in vitro as described in Material
and Methods, and transcriptomic analysis was performed by RNAseq. The table contains the
genes that were significantly upregulated (using DESeq2 statistics) at 7 or 18 h of incubation in
TCM. P value and fold change are also shown.
(XLSX)
S2 Table. Repressed genes during titan-like cell formation. Same as S1 Table, but repressed
genes (p<0.05) are listed.
(XLSX)
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Dedicatory: Óscar Zaragoza would like to dedicate this article to the memory of Dr. Teresa
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